Myles Udland
Mar. 25, 2015, 2:55 PM
2,734
Flickr/Gonzalo IzaBiotech investors have been here before.Stocks are lower on Wednesday and the high-flying biotech sector is leading the way down, with the iShares ETF that tracks the sector falling more than 3%. And as the sector has weakened over the last several days, this sell off is starting to look at lot like the sell […]
I’m baaaack…Yep – back in the saddle after roughing it in the desert for a week. I fended off mountain lion attacks…lost a few bucks betting on March Madness during a detour to Vegas…and meditated on the markets while staring up at the stars.Stocks stabilized in my absence after wandering lower during that pesky early-March pullback. The major averages aren’t […]
View photo.(Bloomberg)The iShares Nasdaq Biotechnology ETF over 12 monthsStocks are selling off on Thursday after a post-Fed rally yesterday.
But biotech stocks are rallying, up nearly 2%. In fact, biotech stocks have been on fire all year. They’re up about 15% year-to-date.Last week, Max Nisen at Quartz wrote that while everyone is focusing on massive tech valuations, the biotech industry is where […]
BloombergThe iShares Nasdaq Biotechnology ETF over 12 months
Stocks sold off on Thursday after a post-Fed rally on Wednesday.
But the Nasdaq still gained ground thanks to the biotech sector which gained about 2% on Thursday. In fact, biotech stocks have been on fire all year. They’re up about 15% year-to-date.Last month, Max Nisen at Quartz wrote that while everyone is focusing on […]
Benchmarks snapped two-day losses to end in the green on Thursday as mixed economic data reduced fears about sooner-than-expected rate hike. Moreover, mixed economic data put the brakes on dollar rally yesterday. Meanwhile, financial stocks posted solid gains after Fed’s stress tests. However, decline in energy shares following oil price slump limited some of yesterday’s gains. The Dow and S&P […]
We have the unusual situation in which many central banks–most notably in Japan and Europe–are pursuing monetary policies of quantitative easing, while the U.S. has been in the mode of exiting its program. The result is that interest rate differential trends across the world–as well as relative economic growth–increasingly support the U.S. dollar. Indeed, as we can see from the […]
Benchmarks suffered huge losses on Tuesday as rate hike fears strengthened the U.S. dollar to a multi-year high against major currencies including the euro. Last week’s strong U.S. job numbers injected fears among investors that the Fed may raise interest rate sooner-than-expected. Moreover, stronger dollar had a negative impact on oil prices yesterday. The blue-chip index witnessed its biggest one-day […]
Markets rebounded to the green on the sixth anniversary of the bull market boosted by mergers and acquisition activity, and gains in industrial and technology stocks. Benchmarks started the week on an encouraging note after a dismal Friday, when positive jobs data had sparked fears of a sooner-than-expected rate hike. Investors also found a buying opportunity yesterday, after the sell […]
MRK -0.30%ABT +0.13%AMGN +0.40%Health care stocks were mostly higher, with the NYSE Health Care Sector Index climbing 0.3% and shares of health care companies in the S&P 500 advancing 0.6% as a group.In company news, Athersys (ATHX) advanced Monday after the biotech company lined up Japanese drugmaker Chugai to help it develop its stem-cell therapy for stoke.Under terms of the […]
Benchmarks ended mostly in the red on Thursday as mixed economic data and another decline in oil prices dampened investor sentiment. However, Avago Technologies’ encouraging deal news and strong earnings results from Salesforce.com boosted technology shares. Meanwhile, small cap stocks outpaced large cap stocks, which in turn helped the Russell 2000 Index reach a record high for the eighth time […]
